Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease.

Morisawa, Norihiko

Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease. [electronic resource] - Clinical and experimental nephrology Oct 2017 - 818-824 p. digital

Publication Type: Journal Article; Observational Study

1437-7799

10.1007/s10157-016-1348-7 doi


Aged
Aged, 80 and over
Antiviral Agents--adverse effects
Carbamates
Drug Therapy, Combination
Female
Genotype
Glomerular Filtration Rate
Hepacivirus--drug effects
Hepatitis C, Chronic--complications
Humans
Imidazoles--adverse effects
Isoquinolines--adverse effects
Japan
Kidney--physiopathology
Longitudinal Studies
Male
Pyrrolidines
RNA, Viral--blood
Renal Insufficiency, Chronic--complications
Retrospective Studies
Sulfonamides--adverse effects
Sustained Virologic Response
Time Factors
Treatment Outcome
Valine--analogs & derivatives
Viral Load